Model
Edge
Alnylam Pharmaceuticals, Inc.
0001226287
Filing type
4
Filing date
May 19, 2024
Updated
May 20, 2024 ยท 2:10 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership